Zhou Wendi, Sharma Madeva, Martinez Joy, Srivastava Tumul, Diamond Don J, Knowles Wendy, Lacey Simon F
Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
Viral Immunol. 2007 Sep;20(3):379-88. doi: 10.1089/vim.2007.0030.
BK polyomavirus (BKV) reactivation is associated with a failure of T cell immunity in kidney transplant patients, and may lead to BKV-associated nephropathy (BKVN) and loss of the allograft. BKV reactivation in hematopoietic stem cell transplant recipients is associated with hemorrhagic cystitis. We have investigated T cell responses to overlapping peptide mixtures corresponding to the whole BKV major T antigen (TAg) and major capsid protein (VP1) in peripheral blood mononuclear cell samples from a cohort of healthy BKV-seropositive subjects. The majority of these individuals possessed populations of both CD8(+) and CD4(+) T cells specific for these BKV antigens. After expansion in culture, the majority of the BKV-specific CD4(+) T cells, in addition to expressing CD40L (CD154), secreted both interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha, contained both granzyme A and granzyme B, and degranulated/mobilized CD107 in response to antigen-specific stimulation. These T cells thus represent potentially functional BKV-specific cytotoxic CD4(+) T lymphocytes. Secretion of both TNF-alpha and IFN-gamma by CD154(+)CD4(+) T cells on BKV-specific stimulation was associated with higher levels of granzyme B and a higher proportion of degranulating cells compared with CD154(+)CD4(+) T cells producing only IFN-gamma or neither cytokine. These healthy subjects also harbored populations of functional CD8(+) T cells specific for one or more of three newly defined HLA-A 02-restricted cytotoxic T lymphocyte epitopes within the BKV TAg as well as two HLA-A 02-restricted epitopes within the BKV VP1 we have previously described. The BKV-specific CD4(+) T cells characterized in this study may play a part in maintaining persistent memory T cell responses to the virus and thus contribute to the immune control of BKV in healthy individuals.
BK多瘤病毒(BKV)再激活与肾移植患者T细胞免疫功能衰竭相关,可能导致BKV相关性肾病(BKVN)和移植肾丧失。造血干细胞移植受者的BKV再激活与出血性膀胱炎相关。我们研究了来自一组健康BKV血清阳性受试者外周血单个核细胞样本中T细胞对与整个BKV大T抗原(TAg)和主要衣壳蛋白(VP1)对应的重叠肽混合物的反应。这些个体中的大多数拥有针对这些BKV抗原的CD8(+)和CD4(+) T细胞群体。在体外培养扩增后,大多数BKV特异性CD4(+) T细胞除了表达CD40L(CD154)外,还分泌干扰素(IFN)-γ和肿瘤坏死因子(TNF)-α,同时含有颗粒酶A和颗粒酶B,并在抗原特异性刺激下脱颗粒/动员CD107。因此,这些T细胞代表了潜在具有功能的BKV特异性细胞毒性CD4(+) T淋巴细胞。与仅产生IFN-γ或不产生任何细胞因子的CD154(+)CD4(+) T细胞相比,BKV特异性刺激下CD154(+)CD4(+) T细胞分泌TNF-α和IFN-γ与更高水平的颗粒酶B以及更高比例的脱颗粒细胞相关。这些健康受试者还拥有针对BKV TAg内三个新定义的HLA-A 02限制性细胞毒性T淋巴细胞表位中的一个或多个以及我们先前描述的BKV VP1内两个HLA-A 02限制性表位的功能性CD8(+) T细胞群体。本研究中表征的BKV特异性CD4(+) T细胞可能在维持对该病毒的持续性记忆T细胞反应中发挥作用,从而有助于健康个体对BKV的免疫控制。